In accordance with section 10(a)2 of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announce the following teleconference meeting:
Name: National Center for Injury Prevention and Control (NCIPC) Initial Review Group (IRG).
Times and Date: 2 p.m.-2:30 p.m. July 15, 2008 (Open).
2:30 p.m.-4 p.m. July 15, 2008 (Closed).
Place: Centers for Disease Control and Prevention, Chamblee Campus, Building 106, 4770 Buford Highway, Atlanta, Georgia 30341. Toll Free: 888-793-2154, Participant Passcode: 4424802.
Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in Sections 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92-463.
Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control.
Matters To Be Discussed: The meeting will include the reconvening of the June 18, 2008 Panel for the peer review of two of the nine applications submitted in response to Fiscal Year 2008 Requests for Applications related to the following individual research announcements: RFA-CE-08-001, Youth Violence Prevention through Community-Level Change (U49); and RFA-CE-08-003, Research for Preventing Violence and Violence-Related Injury (R01). The completion of peer review of applications submitted in response to Fiscal Year 2008 Requests for Applications related to the following individual research announcements: RFA-CD-08-001, Elimination of Health Disparities through Translation Research (R18) (NCIPC); RFA-CD-08-001, Elimination of Health Disparities through Translation Research (R18) (NCEH); RFA-EH-08-002, Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to include Severe Combined Immune Deficiency (SCID) (U01); and RFA-TS-08-003, Environmental Health and Toxicology Research Program (U01).
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Jane Suen, Ph.D., M.S., Executive Secretary, Start Printed Page 39017NCIPC IRG, CDC, 4770 Buford Highway, NE., M/S F-62, Atlanta, Georgia 30341, telephone 770-488-4281.
This notice is published less than 15 days before the meeting due to administrative requirements to reschedule the meeting and to ensure that reviewers would be available on that date. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: June 30, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E8-15399 Filed 7-7-08; 8:45 am]
BILLING CODE 4163-18-P